... San Antonio Breast Cancer Symposium. Business Wire; Dec 11, 2025; 7 mins ... (“Avenzo”), a clinical-stage biotechnology company developing next ...
News
- Avenzo Therapeutics Presents Initial Results from the Phase 1/2 Study of AVZO-021, a ...
- Ed and Linda Whitacre contribute $7 million to support health research, engineering and ...
The University of Texas at San Antonio has received a $7 million gift commitment from longtime philanthropic supporter and former AT&T CEO Ed ...
- Avenzo Therapeutics Presents Initial Results from the Phase 1/2 Study of AVZO-021, a ...
... San Antonio Breast Cancer Symposium. Share. SAN DIEGO, Calif.--(BUSINESS WIRE)--Avenzo Therapeutics, Inc. (“Avenzo”), a clinical-stage biotechnology ...
- 'Are you married?' Why doctors ask invasive questions during treatment
(THE CONVERSATION) It's a rare occasion when my worlds of biomedical informatics and serialized lesbian melodrama fandom collide. ... San Antonio-based ...
- Tivic acquires cGMP assets, secures $90M+ growth financing | TIVC Stock News
... biotech customers. The company validated the Entolimod cell line at ... San Antonio. Velocity Bioworks focuses on rapidly advancing biologic ...